Shire is taking aim at Johnson & Johnson’s ($JNJ) Concerta. The Irish drugmaker is sponsoring two head-to-head trials pitting its ADHD drug Vyvanse against the J&J product as a treatment for adolescents with the disorder. But it’s not just J&J’s…